KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Cash & Current Investments (2016 - 2025)

Moderna (MRNA) has disclosed Cash & Current Investments for 10 consecutive years, with $5.8 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 17.45% to $5.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.8 billion through Dec 2025, down 17.45% year-over-year, with the annual reading at $5.8 billion for FY2025, 17.45% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $5.8 billion at Moderna, up from $4.5 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $10.7 billion in Q4 2021, with the low at $4.5 billion in Q3 2025.
  • Average Cash & Current Investments over 5 years is $7.9 billion, with a median of $8.2 billion recorded in 2021.
  • The sharpest move saw Cash & Current Investments soared 535.07% in 2021, then crashed 39.55% in 2025.
  • Over 5 years, Cash & Current Investments stood at $10.7 billion in 2021, then dropped by 7.69% to $9.9 billion in 2022, then decreased by 13.11% to $8.6 billion in 2023, then dropped by 18.35% to $7.0 billion in 2024, then dropped by 17.45% to $5.8 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $5.8 billion, $4.5 billion, and $5.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.